_id
695fb8d2c2e91020a7bd42a4
Ticker
0IMT.LSE
Name
Photocure ASA
Exchange
LSE
Address
Hoffsveien 4, Oslo, Norway, 0275
Country
UK
Sector
Industry
Currency
NOK
Website
https://www.photocure.com
Description
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, other European Countries, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to license partners, pharmaceutical wholesalers, pharmacies, and hospitals. Photocure ASA was founded in 1997 and is headquartered in Oslo, Norway.
Last Close
73.8
Volume
594
Current Price
74.5
Change
-0.3
Last Updated
2026-01-08T14:01:54.181Z
Ipo Date
-
Market Cap
1462706560
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
134960000
Cost Of Revenue
19224000
Gross Profit
115736000
Operating Expenses
85401000
Operating Income
30335000
Interest Expense
7503000
Pretax Income
-398000
Net Income
3983000
Eps
0.14969929347044983
Dividends Per Share
-
Shares Outstanding
21578600
Income Tax Expense
-4381000
EBITDA
14443000
Operating Margin
22.477030231179608
Total Other Income Expense Net
-30733000
Cash
247771000
Short Term Investments
-
Receivables
92842000
Inventories
33963000
Total Current Assets
374575000
Property Plant Equipment
14484000
Total Assets
696700000
Payables
19365000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
210100000
Equity
486600000
Bs_currency_symbol
-
Depreciation
7338000
Change In Working Capital
15494000
Cash From Operations
31764000
Capital Expenditures
10965000
Cash From Investing
-11036000
Cash From Financing
-12072000
Net Change In Cash
8656000
Cf_currency_symbol
-
PE
-
PB
4.073565688450473
ROE
0.8185367858610768
ROA
0.571695134204105
FCF
20799000
Fcf Percent
0.15411232957913457
Piotroski FScore
4
Health Score
61
Deep Value Investing Score
8
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
6.8
Garp Investing Score
4
Growth Investing Score
3
Momentum Investing Score
3.5
Net Net Investing Score
4
Quality Investing Score
5.5
Value Investing Score
7.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
134960000
Quarters > 0 > income Statement > cost Of Revenue
19224000
Quarters > 0 > income Statement > gross Profit
115736000
Quarters > 0 > income Statement > operating Expenses
85401000
Quarters > 0 > income Statement > operating Income
30335000
Quarters > 0 > income Statement > interest Expense
7503000
Quarters > 0 > income Statement > pretax Income
-398000
Quarters > 0 > income Statement > net Income
3983000
Quarters > 0 > income Statement > eps
0.14969929347044983
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
26606672
Quarters > 0 > income Statement > income Tax Expense
-4381000
Quarters > 0 > income Statement > EBITDA
14443000
Quarters > 0 > income Statement > operating Margin
22.477030231179608
Quarters > 0 > income Statement > total Other Income Expense Net
-30733000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
247771000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
92842000
Quarters > 0 > balance Sheet > inventories
33963000
Quarters > 0 > balance Sheet > total Current Assets
374575000
Quarters > 0 > balance Sheet > property Plant Equipment
14484000
Quarters > 0 > balance Sheet > total Assets
696700000
Quarters > 0 > balance Sheet > payables
19365000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
210100000
Quarters > 0 > balance Sheet > equity
486600000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
3983000
Quarters > 0 > cash Flow > depreciation
7338000
Quarters > 0 > cash Flow > change In Working Capital
15494000
Quarters > 0 > cash Flow > cash From Operations
31764000
Quarters > 0 > cash Flow > capital Expenditures
10965000
Quarters > 0 > cash Flow > cash From Investing
-11036000
Quarters > 0 > cash Flow > cash From Financing
-12072000
Quarters > 0 > cash Flow > net Change In Cash
8656000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.14969929347044983
Quarters > 0 > ratios > PB
4.073565688450473
Quarters > 0 > ratios > ROE
0.8185367858610768
Quarters > 0 > ratios > ROA
0.571695134204105
Quarters > 0 > ratios > FCF
20799000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.15411232957913457
Quarters > 0 > health Score
61
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
135617000
Quarters > 1 > income Statement > cost Of Revenue
10041000
Quarters > 1 > income Statement > gross Profit
125576000
Quarters > 1 > income Statement > operating Expenses
118120000
Quarters > 1 > income Statement > operating Income
7456000
Quarters > 1 > income Statement > interest Expense
9914000
Quarters > 1 > income Statement > pretax Income
2513000
Quarters > 1 > income Statement > net Income
4864000
Quarters > 1 > income Statement > eps
0.18000000148026318
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
27022222
Quarters > 1 > income Statement > income Tax Expense
-2351000
Quarters > 1 > income Statement > EBITDA
19735000
Quarters > 1 > income Statement > operating Margin
5.497835817043586
Quarters > 1 > income Statement > total Other Income Expense Net
-4943000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
239115000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
93635000
Quarters > 1 > balance Sheet > inventories
38150000
Quarters > 1 > balance Sheet > total Current Assets
370900000
Quarters > 1 > balance Sheet > property Plant Equipment
16276000
Quarters > 1 > balance Sheet > total Assets
685373000
Quarters > 1 > balance Sheet > payables
20227000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
205608000
Quarters > 1 > balance Sheet > equity
479765000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
2513000
Quarters > 1 > cash Flow > depreciation
7308000
Quarters > 1 > cash Flow > change In Working Capital
-24484000
Quarters > 1 > cash Flow > cash From Operations
-6846000
Quarters > 1 > cash Flow > capital Expenditures
3065000
Quarters > 1 > cash Flow > cash From Investing
640000
Quarters > 1 > cash Flow > cash From Financing
-14220000
Quarters > 1 > cash Flow > net Change In Cash
-20424000
Quarters > 1 > cash Flow > currency_symbol
NOK
Quarters > 1 > ratios > PE
0.18000000148026318
Quarters > 1 > ratios > PB
4.196128394109616
Quarters > 1 > ratios > ROE
1.013829687451148
Quarters > 1 > ratios > ROA
0.7096865502434441
Quarters > 1 > ratios > FCF
-9911000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.07308080845321752
Quarters > 1 > health Score
46
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
125335000
Quarters > 2 > income Statement > cost Of Revenue
9141000
Quarters > 2 > income Statement > gross Profit
116194000
Quarters > 2 > income Statement > operating Expenses
121769000
Quarters > 2 > income Statement > operating Income
-5575000
Quarters > 2 > income Statement > interest Expense
9010000
Quarters > 2 > income Statement > pretax Income
-9386000
Quarters > 2 > income Statement > net Income
-2411000
Quarters > 2 > income Statement > eps
-0.08987312866514435
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
26826706
Quarters > 2 > income Statement > income Tax Expense
-6975000
Quarters > 2 > income Statement > EBITDA
7019000
Quarters > 2 > income Statement > operating Margin
-4.448079147883672
Quarters > 2 > income Statement > total Other Income Expense Net
-3811000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
259539000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
94402000
Quarters > 2 > balance Sheet > inventories
38212000
Quarters > 2 > balance Sheet > total Current Assets
392153000
Quarters > 2 > balance Sheet > property Plant Equipment
18321000
Quarters > 2 > balance Sheet > total Assets
708555000
Quarters > 2 > balance Sheet > payables
27005000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
236708000
Quarters > 2 > balance Sheet > equity
471847000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-9386000
Quarters > 2 > cash Flow > depreciation
7395000
Quarters > 2 > cash Flow > change In Working Capital
2668000
Quarters > 2 > cash Flow > cash From Operations
4070000
Quarters > 2 > cash Flow > capital Expenditures
2406000
Quarters > 2 > cash Flow > cash From Investing
657000
Quarters > 2 > cash Flow > cash From Financing
-39038000
Quarters > 2 > cash Flow > net Change In Cash
-34312000
Quarters > 2 > cash Flow > currency_symbol
NOK
Quarters > 2 > ratios > PE
-0.08987312866514435
Quarters > 2 > ratios > PB
4.235672997814969
Quarters > 2 > ratios > ROE
-0.5109707172028222
Quarters > 2 > ratios > ROA
-0.34026998609846804
Quarters > 2 > ratios > FCF
1664000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
0.013276419196553237
Quarters > 2 > health Score
26
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
141679000
Quarters > 3 > income Statement > cost Of Revenue
7487000
Quarters > 3 > income Statement > gross Profit
134192000
Quarters > 3 > income Statement > operating Expenses
133009000
Quarters > 3 > income Statement > operating Income
1183000
Quarters > 3 > income Statement > interest Expense
6241000
Quarters > 3 > income Statement > pretax Income
1175000
Quarters > 3 > income Statement > net Income
-5786000
Quarters > 3 > income Statement > eps
-0.20999999963705496
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
27552381
Quarters > 3 > income Statement > income Tax Expense
6962000
Quarters > 3 > income Statement > EBITDA
14690000
Quarters > 3 > income Statement > operating Margin
0.8349861306192167
Quarters > 3 > income Statement > total Other Income Expense Net
-8000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
288834000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
72226000
Quarters > 3 > balance Sheet > inventories
39536000
Quarters > 3 > balance Sheet > total Current Assets
423981000
Quarters > 3 > balance Sheet > property Plant Equipment
20803000
Quarters > 3 > balance Sheet > total Assets
733414000
Quarters > 3 > balance Sheet > payables
19443000
Quarters > 3 > balance Sheet > short Term Debt
21932000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
237372000
Quarters > 3 > balance Sheet > equity
500248000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
1175000
Quarters > 3 > cash Flow > depreciation
7274000
Quarters > 3 > cash Flow > change In Working Capital
-2339000
Quarters > 3 > cash Flow > cash From Operations
15418000
Quarters > 3 > cash Flow > capital Expenditures
4380000
Quarters > 3 > cash Flow > cash From Investing
-1639000
Quarters > 3 > cash Flow > cash From Financing
-10977000
Quarters > 3 > cash Flow > net Change In Cash
2801000
Quarters > 3 > cash Flow > currency_symbol
NOK
Quarters > 3 > ratios > PE
-0.20999999963705496
Quarters > 3 > ratios > PB
4.103269547304537
Quarters > 3 > ratios > ROE
-1.156626313348579
Quarters > 3 > ratios > ROA
-0.78891321954585
Quarters > 3 > ratios > FCF
11038000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.07790851149429344
Quarters > 3 > health Score
37
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
525388000
Annuals > 0 > income Statement > cost Of Revenue
30716000
Annuals > 0 > income Statement > gross Profit
494672000
Annuals > 0 > income Statement > operating Expenses
474272000
Annuals > 0 > income Statement > operating Income
20400000
Annuals > 0 > income Statement > interest Expense
36901000
Annuals > 0 > income Statement > pretax Income
8390000
Annuals > 0 > income Statement > net Income
-4810000
Annuals > 0 > income Statement > eps
-0.17745346384365382
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
27105698
Annuals > 0 > income Statement > income Tax Expense
13199000
Annuals > 0 > income Statement > EBITDA
74089000
Annuals > 0 > income Statement > operating Margin
3.882844678599435
Annuals > 0 > income Statement > total Other Income Expense Net
-12010000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
288834000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
72226000
Annuals > 0 > balance Sheet > inventories
39536000
Annuals > 0 > balance Sheet > total Current Assets
419776000
Annuals > 0 > balance Sheet > property Plant Equipment
20803000
Annuals > 0 > balance Sheet > total Assets
739088000
Annuals > 0 > balance Sheet > payables
19443000
Annuals > 0 > balance Sheet > short Term Debt
6148000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
237372000
Annuals > 0 > balance Sheet > equity
500248000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
8390000
Annuals > 0 > cash Flow > depreciation
28798000
Annuals > 0 > cash Flow > change In Working Capital
2977000
Annuals > 0 > cash Flow > cash From Operations
76751000
Annuals > 0 > cash Flow > capital Expenditures
11446000
Annuals > 0 > cash Flow > cash From Investing
1422000
Annuals > 0 > cash Flow > cash From Financing
-43822000
Annuals > 0 > cash Flow > net Change In Cash
34350000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.17745346384365382
Annuals > 0 > ratios > PB
4.036746775599302
Annuals > 0 > ratios > ROE
-0.9615230845500632
Annuals > 0 > ratios > ROA
-0.6508020695776416
Annuals > 0 > ratios > FCF
65305000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
0.12429861359604712
Annuals > 0 > health Score
41
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
500657000
Annuals > 1 > income Statement > cost Of Revenue
53824000
Annuals > 1 > income Statement > gross Profit
446833000
Annuals > 1 > income Statement > operating Expenses
446713000
Annuals > 1 > income Statement > operating Income
27807000
Annuals > 1 > income Statement > interest Expense
26327000
Annuals > 1 > income Statement > pretax Income
9740000
Annuals > 1 > income Statement > net Income
979000
Annuals > 1 > income Statement > eps
0.03608086610294767
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
27133495
Annuals > 1 > income Statement > income Tax Expense
8761000
Annuals > 1 > income Statement > EBITDA
63754000
Annuals > 1 > income Statement > operating Margin
5.554101910090141
Annuals > 1 > income Statement > total Other Income Expense Net
-18067000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
256336000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
64385000
Annuals > 1 > balance Sheet > inventories
37190000
Annuals > 1 > balance Sheet > total Current Assets
372431000
Annuals > 1 > balance Sheet > property Plant Equipment
24128000
Annuals > 1 > balance Sheet > total Assets
711973000
Annuals > 1 > balance Sheet > payables
19660000
Annuals > 1 > balance Sheet > short Term Debt
19630000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
229125000
Annuals > 1 > balance Sheet > equity
482848000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
9740000
Annuals > 1 > cash Flow > depreciation
27687000
Annuals > 1 > cash Flow > change In Working Capital
-11745000
Annuals > 1 > cash Flow > cash From Operations
48307000
Annuals > 1 > cash Flow > capital Expenditures
12306000
Annuals > 1 > cash Flow > cash From Investing
-594000
Annuals > 1 > cash Flow > cash From Financing
-56284000
Annuals > 1 > cash Flow > net Change In Cash
-8569000
Annuals > 1 > cash Flow > currency_symbol
NOK
Annuals > 1 > ratios > PE
0.03608086610294767
Annuals > 1 > ratios > PB
4.1865046091109415
Annuals > 1 > ratios > ROE
0.20275531844389955
Annuals > 1 > ratios > ROA
0.1375052143831297
Annuals > 1 > ratios > FCF
36001000
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
0.07190751352722523
Annuals > 1 > health Score
51
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
393132000
Annuals > 2 > income Statement > cost Of Revenue
22697000
Annuals > 2 > income Statement > gross Profit
370435000
Annuals > 2 > income Statement > operating Expenses
419437000
Annuals > 2 > income Statement > operating Income
-49003000
Annuals > 2 > income Statement > interest Expense
25804000
Annuals > 2 > income Statement > pretax Income
-71134000
Annuals > 2 > income Statement > net Income
-71857000
Annuals > 2 > income Statement > eps
-2.6579272716942675
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
27034976
Annuals > 2 > income Statement > income Tax Expense
723000
Annuals > 2 > income Statement > EBITDA
-20952000
Annuals > 2 > income Statement > operating Margin
-12.464770102662719
Annuals > 2 > income Statement > total Other Income Expense Net
-22131000
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
264651000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
54506000
Annuals > 2 > balance Sheet > inventories
26535000
Annuals > 2 > balance Sheet > total Current Assets
358226000
Annuals > 2 > balance Sheet > property Plant Equipment
30806000
Annuals > 2 > balance Sheet > total Assets
719034000
Annuals > 2 > balance Sheet > payables
21281000
Annuals > 2 > balance Sheet > short Term Debt
27382000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
256301000
Annuals > 2 > balance Sheet > equity
462733000
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
-71134000
Annuals > 2 > cash Flow > depreciation
24378000
Annuals > 2 > cash Flow > change In Working Capital
-181000
Annuals > 2 > cash Flow > cash From Operations
-2018000
Annuals > 2 > cash Flow > capital Expenditures
3609000
Annuals > 2 > cash Flow > cash From Investing
-1462000
Annuals > 2 > cash Flow > cash From Financing
-51342000
Annuals > 2 > cash Flow > net Change In Cash
-54822000
Annuals > 2 > cash Flow > currency_symbol
NOK
Annuals > 2 > ratios > PE
-2.6579272716942675
Annuals > 2 > ratios > PB
4.352630376480605
Annuals > 2 > ratios > ROE
-15.528825478191527
Annuals > 2 > ratios > ROA
-9.993546897643228
Annuals > 2 > ratios > FCF
-5627000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.014313258651038328
Annuals > 2 > health Score
25
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
360540000
Annuals > 3 > income Statement > cost Of Revenue
24050000
Annuals > 3 > income Statement > gross Profit
336490000
Annuals > 3 > income Statement > operating Expenses
342316000
Annuals > 3 > income Statement > operating Income
9390000
Annuals > 3 > income Statement > interest Expense
23826000
Annuals > 3 > income Statement > pretax Income
-31656000
Annuals > 3 > income Statement > net Income
-30897000
Annuals > 3 > income Statement > eps
-1.1510119737357523
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
26843335
Annuals > 3 > income Statement > income Tax Expense
-759000
Annuals > 3 > income Statement > EBITDA
16821000
Annuals > 3 > income Statement > operating Margin
2.604426693293393
Annuals > 3 > income Statement > total Other Income Expense Net
-25830000
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
319039000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
52908000
Annuals > 3 > balance Sheet > inventories
27535000
Annuals > 3 > balance Sheet > total Current Assets
413189000
Annuals > 3 > balance Sheet > property Plant Equipment
32420000
Annuals > 3 > balance Sheet > total Assets
789648000
Annuals > 3 > balance Sheet > payables
23648000
Annuals > 3 > balance Sheet > short Term Debt
36580000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
287015000
Annuals > 3 > balance Sheet > equity
502633000
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-31656000
Annuals > 3 > cash Flow > depreciation
24127000
Annuals > 3 > cash Flow > change In Working Capital
-3222000
Annuals > 3 > cash Flow > cash From Operations
23886000
Annuals > 3 > cash Flow > capital Expenditures
3703000
Annuals > 3 > cash Flow > cash From Investing
-1896000
Annuals > 3 > cash Flow > cash From Financing
-33983000
Annuals > 3 > cash Flow > net Change In Cash
-11992000
Annuals > 3 > cash Flow > currency_symbol
NOK
Annuals > 3 > ratios > PE
-1.1510119737357523
Annuals > 3 > ratios > PB
3.978705054184664
Annuals > 3 > ratios > ROE
-6.147029741381884
Annuals > 3 > ratios > ROA
-3.9127560634611878
Annuals > 3 > ratios > FCF
20183000
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
0.05597991901037333
Annuals > 3 > health Score
30
Valuation > metrics > PE
0.14969929347044983
Valuation > metrics > PB
4.073565688450473
Valuation > final Score
59.26434311549527
Valuation > verdict
31.4% Undervalued
Profitability > metrics > ROE
0.8185367858610768
Profitability > metrics > ROA
1.0633384502436094
Profitability > metrics > Net Margin
0.029512448132780082
Profitability > final Score
9
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.43177147554459516
Risk > metrics > Interest Coverage
4.0430494468879115
Risk > final Score
76
Risk > verdict
Low
Liquidity > metrics > Current Ratio
19.3428866511748
Liquidity > metrics > Quick Ratio
17.58905241414924
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
58.038716058903844
Prev Valuations > 1
37.643270021850306
Prev Valuations > 2
38.967304526954635
Prev Profitabilities > 0
11
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
63
Prev Risks > 1
46
Prev Risks > 2
61
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:13:36.148Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-18
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, other European Countries, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to license partners, pharmaceutical wholesalers, pharmacies, and hospitals. Photocure ASA was founded in 1997 and is headquartered in Oslo, Norway.
Stock Price
NOK0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Photocure ASA
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
NOK 0
Cost Of Revenue
NOK 0
Gross Profit
NOK 0
Operating Expenses
NOK 0
Operating Income
NOK 0
Interest Expense
NOK 0
Pretax Income
NOK 0
Net Income
NOK 0
Income Tax Expense
NOK 0
EBITDA
NOK 0
Total Other Income Expense Net
NOK 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
NOK 0
Short Term Investments
NOK 0
Receivables
NOK 0
Inventories
NOK 0
Total Current Assets
NOK 0
Property Plant Equipment
NOK 0
Total Assets
NOK 0
Payables
NOK 0
Short Term Debt
NOK 0
Long Term Debt
NOK 0
Total Liabilities
NOK 0
Equity
NOK 0
(Last Updated 2025-09-30)
Net Income
NOK 0
Depreciation
NOK 0
Change In Working Capital
NOK 0
Cash From Operations
NOK 0
Capital Expenditures
NOK 0
Cash From Investing
NOK 0
Cash From Financing
NOK 0
Net Change In Cash
NOK 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.